These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2706639)

  • 1. A preliminary pharmacokinetic study of 111In-labeled 260F9 anti-(breast cancer) antibody in patients.
    Griffin TW; Bokhari F; Collins J; Stochl M; Bernier M; Gionet M; Siebecker D; Wertheimer M; Giroves ES; Greenfield L
    Cancer Immunol Immunother; 1989; 29(1):43-50. PubMed ID: 2706639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of 111In-labeled anti-p97 monoclonal antibody in patients with metastatic malignant melanoma.
    Rosenblum MG; Murray JL; Haynie TP; Glenn HJ; Jahns MF; Benjamin RS; Frincke JM; Carlo DJ; Hersh EM
    Cancer Res; 1985 May; 45(5):2382-6. PubMed ID: 3986780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Initial clinical study of indium-111-labeled clone 110 anticarcinoembryonic antigen antibody in patients with colorectal cancer.
    Griffin TW; Brill AB; Stevens S; Collins JA; Bokhari F; Bushe H; Stochl MC; Gionet M; Rusckowski M; Stroupe SD
    J Clin Oncol; 1991 Apr; 9(4):631-40. PubMed ID: 2066759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose escalation trial of indium-111-labeled anti-carcinoembryonic antigen chimeric monoclonal antibody (chimeric T84.66) in presurgical colorectal cancer patients.
    Wong JY; Chu DZ; Yamauchi D; Odom-Maryon TL; Williams LE; Liu A; Esteban JM; Wu AM; Primus FJ; Beatty JD; Shively JE; Raubitschek AA
    J Nucl Med; 1998 Dec; 39(12):2097-104. PubMed ID: 9867150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics in patients of an anti-carcinoembryonic antigen antibody radiolabeled with indium-111 using a novel diethylenetriamine pentaacetic acid chelator.
    Hnatowich DJ; Rusckowski M; Brill AB; Siebecker DA; Misra H; Mardirossian G; Bushe H; Rescigno A; Stevens S; Johnson DK
    Cancer Res; 1990 Nov; 50(22):7272-8. PubMed ID: 2224858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunospecific saturable clearance mechanisms for indium-111-labeled anti-melanoma monoclonal antibody 96.5 in humans.
    Murray JL; Lamki LM; Shanken LJ; Blake ME; Plager CE; Benjamin RS; Schweighardt S; Unger MW; Rosenblum MG
    Cancer Res; 1988 Aug; 48(15):4417-22. PubMed ID: 3390837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative clinical pharmacology of [111In]-labeled murine monoclonal antibodies.
    Rosenblum MG; Murray JL; Lamki L; David G; Carlo D
    Cancer Chemother Pharmacol; 1987; 20(1):41-7. PubMed ID: 3621452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase I study of 90Y-labeled B72.3 intraperitoneal administration in patients with ovarian cancer: effect of dose and EDTA coadministration on pharmacokinetics and toxicity.
    Rosenblum MG; Verschraegen CF; Murray JL; Kudelka AP; Gano J; Cheung L; Kavanagh JJ
    Clin Cancer Res; 1999 May; 5(5):953-61. PubMed ID: 10353726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics, biodistribution, and gamma camera imaging of 111In-KC-4G3 murine monoclonal antibody in athymic nude mice with or without human tumor xenografts.
    Longley C; Furmanski P; Dienhart DG; Lear J; Bloedow D; Kasliwal R; Bunn PA
    Cancer Res; 1990 Sep; 50(18):5954-61. PubMed ID: 2393864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imaging and phase I study of 111In- and 90Y-labeled anti-LewisY monoclonal antibody B3.
    Pai-Scherf LH; Carrasquillo JA; Paik C; Gansow O; Whatley M; Pearson D; Webber K; Hamilton M; Allegra C; Brechbiel M; Willingham MC; Pastan I
    Clin Cancer Res; 2000 May; 6(5):1720-30. PubMed ID: 10815890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo biodistribution of a humanized anti-Lewis Y monoclonal antibody (hu3S193) in MCF-7 xenografted BALB/c nude mice.
    Clarke K; Lee FT; Brechbiel MW; Smyth FE; Old LJ; Scott AM
    Cancer Res; 2000 Sep; 60(17):4804-11. PubMed ID: 10987290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of decreasing liver uptake of 111In-labeled anti-carcinoembryonic antigen monoclonal antibody by specific antibody pretreatment in tumor bearing mice.
    Beatty BG; O'Conner-Tressel M; Do T; Paxton RJ; Beatty JD
    Cancer Res; 1990 Feb; 50(3 Suppl):846s-851s. PubMed ID: 2297732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pretherapy biodistribution and dosimetry study of indium-111-radiolabeled trastuzumab in patients with human epidermal growth factor receptor 2-overexpressing breast cancer.
    Wong JY; Raubitschek A; Yamauchi D; Williams LE; Wu AM; Yazaki P; Shively JE; Colcher D; Somlo G
    Cancer Biother Radiopharm; 2010 Aug; 25(4):387-94. PubMed ID: 20707718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of circulating antigen and radiolabel stability on the biodistribution of an indium labelled antibody.
    Davidson BR; Babich J; Young H; Waddington W; Clarke G; Short M; Boulos P; Styles J; Dean C
    Br J Cancer; 1991 Nov; 64(5):850-6. PubMed ID: 1931605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical evaluation of indium-111-labeled chimeric anti-CEA monoclonal antibody.
    Wong JY; Thomas GE; Yamauchi D; Williams LE; Odom-Maryon TL; Liu A; Esteban JM; Neumaier M; Dresse S; Wu AM; Primus FJ; Shively JE; Raubitschek AA
    J Nucl Med; 1997 Dec; 38(12):1951-9. PubMed ID: 9430476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of an indium-labeled IgG monoclonal antibody over a prolonged period.
    Halpern SE; Bartholomew R
    Eur J Nucl Med; 1995 Nov; 22(11):1323-5. PubMed ID: 8575485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Localization of sarcoma xenografts in nude mice with indium-111-labeled monoclonal antibodies.
    Chao TC; Blend MJ; Lopes AD; Atcher RW; Das Gupta TK; Greager JA
    J Surg Res; 1993 Jul; 55(1):38-43. PubMed ID: 8412080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biokinetics of a F(ab')3 iodine-131 labeled antigen binding construct (Mab 35) directed against CEA in patients with colorectal carcinoma.
    Storto G; Buchegger F; Waibel R; Kuenzi G; Offord RE; Schubiger PA; Gillet M; Delaloye AB
    Cancer Biother Radiopharm; 2001 Oct; 16(5):371-9. PubMed ID: 11776754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraperitoneal 131I- and 111In-791T/36 monoclonal antibody in recurrent ovarian cancer: imaging and biodistribution.
    Perkins AC; Pimm MV; Gie C; Marksman RA; Symonds EM; Baldwin RW
    Nucl Med Commun; 1989 Aug; 10(8):577-84. PubMed ID: 2812640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Initial clinical evaluation of radiolabeled MX-DTPA humanized BrE-3 antibody in patients with advanced breast cancer.
    Kramer EL; Liebes L; Wasserheit C; Noz ME; Blank EW; Zabalegui A; Melamed J; Furmanski P; Peterson JA; Ceriani RL
    Clin Cancer Res; 1998 Jul; 4(7):1679-88. PubMed ID: 9676842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.